Current data indicate that the biomarkers Golgi protein 73 (GP73), GPC-3 and AFP offer much better fidelity for the diagnosis of HCC when investigated together than alone or in pairs [42,43,44]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.